Recro Pharma REPH
$ 1.4
-4.76%
Annual report 2023
added 03-22-2024
Recro Pharma Balance Sheet 2011-2024 | REPH
Annual Balance Sheet Recro Pharma
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-6.65 M | 17.1 M | 71.3 M | 85.8 M | 91.7 M | 25.7 M | -3.89 M | -40.1 M | 9.98 M | -19.7 M | -188 K | 10.1 M | 8.14 M |
Long Term Debt |
339 K | 31 M | 95.5 M | 108 M | 110 M | 64.2 M | 53.6 M | 22.2 M | 25.2 M | - | - | - | - |
Long Term Debt Current |
1.1 M | 1.08 M | 1.06 M | 1.47 M | 148 K | - | - | 2.24 M | 4.52 M | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | 111 M | 146 M | 107 M | 95.1 M | 88.9 M | - | - | 5.44 M | 5.03 M |
Total Current Liabilities |
50 M | 22.8 M | 17.7 M | 7.8 M | 6.48 M | 29 M | 49.9 M | 16.3 M | 9.49 M | 1.45 M | - | - | - |
Total Liabilities |
94.8 M | 97.6 M | 118 M | 118 M | 117 M | 175 M | 157 M | 111 M | 98.3 M | 1.45 M | 1.02 M | 15.7 M | 13.6 M |
Deferred Revenue |
543 K | 2.21 M | 2.31 M | 1.45 M | 337 K | 66 K | 546 K | 418 K | - | - | - | - | - |
Retained Earnings |
-279 M | -266 M | -246 M | -234 M | -207 M | -188 M | -111 M | -61.3 M | -31.1 M | -34.1 M | -18 M | -15.6 M | -13.6 M |
Total Assets |
153 M | 157 M | 160 M | 103 M | 110 M | 155 M | 186 M | 183 M | 139 M | 20.4 M | 1.03 M | 154 K | 25.7 K |
Cash and Cash Equivalents |
8.1 M | 15 M | 25.2 M | 23.8 M | 19.1 M | 38.5 M | 61 M | 64.5 M | 19.8 M | 19.7 M | 12.8 K | - | - |
Book Value |
58.7 M | 59.9 M | 42.1 M | -14.1 M | -6.71 M | -19.5 M | 28.8 M | 71.6 M | 40.4 M | 18.9 M | 2.34 K | -15.6 M | -13.6 M |
Total Shareholders Equity |
58.7 M | 59.9 M | 42.1 M | -14.1 M | -6.71 M | -19.5 M | 28.8 M | 71.6 M | 40.4 M | 18.9 M | -18 M | - | - |
All numbers in USD currency
Quarterly Balance Sheet Recro Pharma
2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
27.4 M | 31 M | 30.5 M | 31 M | 95.5 M | 94.4 M | 93.2 M | 92.1 M | 91 M | 89.8 M | 88.9 M | 108 M | 108 M | 108 M | 108 M | 110 M | 110 M | 110 M | 110 M | 64.2 M | 64.2 M | 64.2 M | 64.2 M | 53.6 M | 53.6 M | 53.6 M | 53.6 M | 22.2 M | 22.2 M | 22.2 M | 22.2 M | 25.2 M | 25.2 M | 25.2 M | 25.2 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
93.3 M | 94.4 M | 94 M | 97.6 M | 116 M | 116 M | 113 M | 118 M | 113 M | 96 M | 98.3 M | 118 M | 118 M | 118 M | 118 M | 117 M | 117 M | 117 M | 117 M | 175 M | 175 M | 175 M | 175 M | 157 M | 157 M | 157 M | 157 M | 111 M | 111 M | 111 M | 111 M | 98.3 M | 98.3 M | 98.3 M | 98.3 M | 1.45 M | 1.45 M | 1.45 M | 1.45 M | 12.9 M | 12.9 M | 12.9 M | 12.9 M | - | - | - | - | - | - | - | - |
Deferred Revenue |
1.31 M | 1.28 M | 1.76 M | 2.21 M | 2.37 M | 2.22 M | 1.84 M | 2.31 M | 2.32 M | 1.07 M | 1.4 M | 1.45 M | 1.45 M | 1.45 M | 786 K | 337 K | 775 K | 637 K | 548 K | 66 K | 66 K | 66 K | 66 K | 546 K | 546 K | 546 K | 546 K | 418 K | 418 K | 418 K | 418 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-278 M | -274 M | -270 M | -266 M | -256 M | -253 M | -250 M | -246 M | -243 M | -240 M | -241 M | -234 M | -234 M | -234 M | -234 M | -207 M | -207 M | -207 M | -207 M | -188 M | -188 M | -188 M | -188 M | -111 M | -111 M | -111 M | -111 M | -61.3 M | -61.3 M | -61.3 M | -61.3 M | -31.1 M | -31.1 M | -31.1 M | -31.1 M | -34.1 M | -34.1 M | -34.1 M | -34.1 M | -18 M | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
152 M | 149 M | 150 M | 157 M | 151 M | 153 M | 152 M | 160 M | 158 M | 122 M | 89.6 M | 103 M | 103 M | 103 M | 103 M | 110 M | 110 M | 110 M | 110 M | 155 M | 155 M | 155 M | 155 M | 186 M | 186 M | 186 M | 186 M | 183 M | 183 M | 183 M | 183 M | 139 M | 139 M | 139 M | 139 M | 20.4 M | 20.4 M | 20.4 M | 20.4 M | 851 K | 851 K | 851 K | 851 K | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
8.16 M | 4.7 M | 6.29 M | 15 M | 11.6 M | 15.5 M | 15.3 M | 25.2 M | 23.5 M | 45.7 M | 11.6 M | 23.8 M | 23.8 M | 23.8 M | 23.8 M | 19.1 M | 19.1 M | 19.1 M | 19.1 M | 38.5 M | 38.5 M | 38.5 M | 38.5 M | 61 M | 61 M | 61 M | 61 M | 64.5 M | 64.5 M | 64.5 M | 64.5 M | 19.8 M | 19.8 M | 19.8 M | 19.8 M | 19.7 M | 19.7 M | 19.7 M | 19.7 M | 13 K | 12.8 K | 12.8 K | 12.8 K | 53.3 K | - | - | - | - | - | - | - |
Book Value |
58.3 M | 54.3 M | 56 M | 59.9 M | 35.2 M | 37.3 M | 39.2 M | 42.1 M | 44.5 M | 26.4 M | -8.72 M | -14.1 M | -14.1 M | -14.1 M | -14.1 M | -6.71 M | -6.71 M | -6.71 M | -6.71 M | -19.5 M | -19.5 M | -19.5 M | -19.5 M | 28.8 M | 28.8 M | 28.8 M | 28.8 M | 71.6 M | 71.6 M | 71.6 M | 71.6 M | 40.4 M | 40.4 M | 40.4 M | 40.4 M | 18.9 M | 18.9 M | 18.9 M | 18.9 M | -12.1 M | -12.1 M | -12.1 M | -12.1 M | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
58.3 M | 54.3 M | 56 M | 59.9 M | 35.2 M | 37.3 M | 39.2 M | 42.1 M | 44.5 M | 26.4 M | -8.72 M | -14.1 M | -14.1 M | -14.1 M | -14.1 M | -6.71 M | -6.71 M | -6.71 M | -6.71 M | -19.5 M | -19.5 M | -19.5 M | -19.5 M | 28.8 M | 28.8 M | 28.8 M | 28.8 M | 71.6 M | 71.6 M | 71.6 M | 71.6 M | 40.4 M | 40.4 M | 40.4 M | 40.4 M | 18.9 M | 18.9 M | 18.9 M | 18.9 M | -18 M | -18 M | -18 M | -18 M | -15.6 M | - | - | - | - | - | - | - |
All numbers in USD currency